WHO was the first major organization to produce a definition of the metabolic syndrome that focused mainly on insulin resistance, whose diagnosis requires an oral glucose tolerance test.
WHO criteria also proposed that microalbuminuria as a marker to identify high-risk patients with the metabolic syndrome.
In response to WHO, EGIR sought to establish criteria that would be easier to use in clinical practice. EGIR makes measuring insulin resistance mandatory.
The AACE position does not provide a specific scoring system for diagnosing the “insulin resistance syndrome”. Insulin resistance is at the core of AACE criteria, while waist circumference is not considered a diagnosis criterion.
These organizations acknowledge that their diagnosis tools can be refined and that further research is needed to improve diagnosis of the metabolic syndrome in clinical practice.
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 2008;94:457-62